First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection. Gane EJ, Kim W, Lim TH, Tangkijvanich P, et al. J Hepatol 2023 Jul 29:S0168-8278(23)05005-5. doi: 10.1016/j.jhep.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Gane EJ, Kim W, Lim TH, Tangkijvanich P, et al. First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection. J Hepatol 2023 Jul 29:S0168-8278(23)05005-5. doi: 10.1016/j.jhep.2023.
PMID: 37524230